$33.310
+0.333 (+1.00%)At close
GCO News
GCO Events
Genesco Shareholders Re-elect Nine Directors
Genesco announced that, based on preliminary voting results provided by its proxy solicitor following the Company's 2026 Annual Meeting of Shareholders, Genesco shareholders have voted to re-elect all nine of its highly qualified director nominees - Gregory Sandfort, Mimi Vaughn, Joanna Barsh, Matt Bilunas, Carolyn Bojanowski, John Lambros, Thurgood Marshall, Jr., Angel Martinez, and Mary Meixelsperger - to the Company's Board of Directors. Genesco issued the following statement: "We greatly appreciate the strong support of Genesco's shareholders in electing all nine of the Company's directors, and the confidence they have shown in our Board, management team and Footwear First strategy to create shareholder value. We are advancing our four strategic growth drivers - curate and create winning product; elevate distinctive brands; create exceptional customer experiences; and build amazing teams. Our full focus is on continuing to build on the clear momentum our organization has underway. We are confident in our path forward and excited to capitalize on the opportunities we see ahead for our brands."
Genesco Shareholder Meeting Independent Advisors Recommend Supporting Management Nominees
Genesco announced that independent proxy advisory firms Institutional Shareholder Services recommends that shareholders vote for all nine of the company's directors on the white proxy card in connection with its upcoming 2026 Annual Meeting of Shareholders, which is scheduled to be held on July 21. In their report dated July 6, ISS stated, according to Genesco: "the dissidents have not made a compelling case for change. As such, support for all management nominees on the management card is warranted. Shareholders are also recommended to withhold votes from the dissidents' nominees, Ballard and Poskon."
Jumana Capital Rebuts Misleading Claims by Genesco
Bradley Radoff, Jumana Capital Investments and Christopher Martin, who collectively own approximately 9.1% of the outstanding shares of Genesco, released a rebuttal presentation spotlighting several "false and misleading" claims made in the Company's July 1, 2026 presentation. The Radoff-Jumana Group also issued the following statement: "Given the Board's latest manipulation of the facts, we once again call for Ms. Vaughn to be stripped of the Chair role. It is clear to us that there is zero accountability in the boardroom so long as Ms. Vaughn is calling the shots. In fact, the Board should promote Andrew Gray to CEO if Ms. Vaughn continues to waste shareholder resources in an attempt to mislead investors and maintain her grip on the Company - he is effectively already running the business as CEO of the profitable Journeys segment. We also urge the Company to conduct a Dutch tender offer for 1 million shares. The Company has excess cash, in our view, following its receipt of a $58.7M tax refund and anticipated $23-$25M tariff refund. With excess real estate, inventory and overhead costs, we demand all excess cash be returned to shareholders at the soonest possible opportunity."
Genesco Appoints Jonathan Collins as CFO
Genesco (GCO) announced the appointment of Jonathan Collins as Senior Vice President, Finance and CFO, effective August 3, following a comprehensive search process. Collins will report directly to Genesco Board Chair, President and CEO Mimi Vaughn, who has served as Interim CFO since March 2026. Collins brings an impressive record of more than 30 years of senior financial experience. He spent more than a decade with Walmart (WMT) from 2012 to 2025 in a series of successive executive leadership roles.
Dell's Strong Earnings Propel Tech Stocks Higher
The major averages closed higher on the last trading day of the month as Dell's blowout results helped add fuel to the ongoing rally in tech.Oil prices pulled back amid further diplomatic signaling around Iran, although it was reported that Iran's armed forces fired missiles late Thursday and President Trump said in a social media post that he was meeting to decide if he would approve a deal to extend the ceasefire.Get caught up quickly on the top news and calls moving stocks with these five Top Five lists.1. STOCK NEWS:Dell Technologiesprovided areport for Q1Costcoreported, though comparable-store sales rose 9.8% year-over-yearGapreportedand raised its FY26 net interest income outlookAutodeskprovided areport for Q1 and agreed to acquire MaintainX in a deal valued at $3.6BSeveral space stocks, including AST SpaceMobile, EchoStar, and Rocket Lab, were slipping after Blue Origin's New Glenn rocketin Cape Canaveral2. WALL STREET CALLS:SusquehannaDellto Positive, hiked its price target to $700HSBCSnowflaketo Buy on AI visibilityDeutscheAST SpaceMobileafter the Blue Origin New Glenn rocket explosionBest Buyto Neutral at UBSSentinelOneto Buy at BofA and downgraded to Market Perform at Raymond James after Q1 report3. AROUND THE WEB:Mercedes-Benzcould be shut out of U.S. car market under a new bill, CNBC reportsNvidia'splans to launch Rubin CPX, an inference-focused graphics processing unit for its Vera Rubin platform, has become "increasingly uncertain" as supply chain activity around the product appears to have stalled, The Elec saysMetais creating an Enterprise Solutions unit that embeds engineers and product managers directly with large corporate customers to accelerate adoption and deployment of its AI tools, The Information reportsJD.comfounder Liu Qiangdong has pledged to prioritize protecting the company's roughly 900,000 employees from AI-driven automation, Bloomberg reportsMassachusetts Attorney General Andrea Joy Campbell is suing UnitedHealth'sUnitedHealthcare, alleging the subsidiary purposefully made low-income older adults appear sicker to boost its bottom line, Stat News says4. MOVERS:Replimuneincreases afterfor RP1 in combination with nivolumab following communications with the FDANetAppand PagerDutywere higher afterOktagained afterand raising its guidance for FY27Ambarellafell afterand providing guidance for Q2iHeartMediawas lower after DealBooktalks over a potential sale to Sirius XMare on pause5. EARNINGS/GUIDANCE:Genescoand raised its guidance for FY27Elmet, with EPS and revenue beating consensusTempus AIreiteratedHealthEquityand raised its guidance for FY27UiPath, provided guidance for Q2, and raised its outlook for FY27INDEXES:The Dow rose 363.49, or 0.72%, to 51,032.46, the Nasdaq gained 55.15, or 0.20%, to 26,972.62, and the S&P 500 advanced 16.43, or 0.22%, to 7,580.06.
This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.